ARO is thrilled to offer two satellite symposia and two gEAR workshops on Friday, February 21st. We will also offer a number of pre-event virtual sessions. Keep an eye out for additional details as they become available.
Pharmaceutical Interventions for Hearing Loss (PIHL) Satellite Symposium
- Friday, February 21, 2025, from 1:00 PM - 5:00 PM EST (local time)
- Organized by the Department of Defense Hearing Center of Excellence Pharmaceutical Interventions for Hearing Loss (DoD HCE PIHL) committee. The topic of this meeting is "Investigational medicines for hearing loss prevention and hearing restoration". This is a highly timely topic given both the approval of the first medicine for prevention of cisplatin ototoxicity (PedMark) and the highly promising outcomes from Otoferlin gene therapy interventions presented at the presidential symposium at the 2024 ARO midwinter meeting. Speakers at the session will include ARO members and others who choose to attend ARO after learning about this session.
Ménière’s Disease Satellite Symposium
- Friday, February 21, 2025, from 2:00 PM - 6:00 PM EST (local time)
- Ménière’s disease is a disorder of the inner ear that includes episodes of vertigo with possible hearing loss and related symptoms, including ringing or buzzing in the ear and a feeling of pressure or “fullness” in the ear. Episodic in nature, Ménière’s can take months or even years to diagnose, which adds to the challenges faced by those suffering from its symptoms. This symposium will bring together researchers, clinicians, and patient perspectives to survey the current state of research and clinical approaches to Ménière’s disease. It will identify knowledge gaps and barriers to advancing research on, and treatment of, this disorder. The session is organized in two parts.
|